SURGERY AND PERIOPERATIVE CARE (CR MACKENZIE AND SM GOODMAN, SECTION EDITORS)

Current Rheumatology Reports

, 15:354

Cardiovascular Risk in the Rheumatic Disease Patient Undergoing Orthopedic Surgery

  • Susan M. GoodmanAffiliated withHospital for Special Surgery, Weill Cornell College of Medicine Email author 
  • , C. Ronald MackenzieAffiliated withHospital for Special Surgery, Weill Cornell College of Medicine

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

A hallmark of the rheumatic diseases, including systemic lupus erythematosis, spondyloarthritis, and rheumatoid arthritis, has been sustained inflammation, which typically targets the joint and may lead to joint destruction. Inflammation also plays a role in atherosclerotic cardiovascular disease, which is highly prevalent in patients with rheumatic diseases. Total joint arthroplasty, considered an intermediate cardiac risk procedure by the American College of Cardiology, maintains an important role in the management of rheumatic disease patients who progress to end-stage joints. The purpose of this article is to discuss the role of inflammation in cardiovascular disease, the prevalence of cardiovascular disease in patients with systemic rheumatic diseases, and the role of cardiovascular risk assessment when these patients undergo total joint arthroplasty.

Keywords

Arthroplasty Rheumatic diseases Atherosclerosis Perioperative cardiac risk Cardiovascular risk Orthopedic surgery Coronary artery disease Inflammation Spondyloarthritis Rheumatoid arthritis Psoriatic arthritis Systemic lupus erythematosus